ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published on March 17, 2008
Interactive CardioVascular and Thoracic Surgery 2008, doi:10.1510/icvts.2008.176156
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (Journal Format PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eComments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Mastoraki, A.
Right arrow Articles by Geroulanos, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mastoraki, A.
Right arrow Articles by Geroulanos, S.
Related Collections
Right arrow Esophagus - cancer

Cardiac general

Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery

Aikaterini Mastoraki 1*, Ioannis Kriaras 1, Evangelia Douka 1, Sotiria Mastoraki 1, Georgios Stravopodis 1, Stephanos Geroulanos 1

1 Onassis Cardiac Surgery Center, Athens, Greece

* To whom correspondence should be addressed. E-mail: dr_kamast{at}yahoo.gr.


   Abstract
Objectives: The aim of this survey was to elucidate the efficacy of methicillin-resistant Staphylococcus aureus (MRSA) preventing strategy in our institution by investigating the incidence and evaluating the morbidity and mortality associated with this multi-resistant virulent organism. Methods: A prospective observational cohort among patients submitted to cardiovascular surgical procedures was conducted from 01/01/97 to 31/12/05. Preventing strategy included active screening programs by nasal swabs for all patients admitted from other hospitals or being at risk for developing infectious complications. Carriers or infected patients remained isolated and were treated promptly. Furthermore all newly employed health care workers were screened for MRSA and carriers were treated with mupirocin until the eradication of the pathogen. Results: Throughout the 9-year study period 826 infectious complications were registered among 15270 cardiac surgical patients. Total infection rate was 5.4%. MRSA was identified in 86 patients; 56 patients proved carriers and 30 infected. The MRSA associated infection rate was 0.2%. During this period of time mean ICU stay was 1.7 days and ICU mortality rate 2.9%. MRSA infected patients presented a mean ICU stay of 46.5 days and a mortality rate of 30%. In 10 patients MRSA was detected in tracheal secretions, in 4 patients in swabs taken from donor site infection and in 4 patients from superficial sternal surgical wound. In 10 patients the pathogen was isolated from cultures of the surgical site drainage and the diagnosis of post-sternotomy mediastinitis was confirmed. The remaining 2 patients were defined as having severe sepsis; MRSA was documented in central venous catheter tips and blood cultures. Conclusions: The prompt determination, isolation and appropriate treatment of MRSA patients admitted from other institutions combined with the detection and elimination of carriers among new health care workers and patients at high risk of developing infectious complications prevented further spread of the pathogen. Keywords: MRSA; Preventing strategy; Cardiac surgery





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-thoracic Surgery